Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on 08th August, 2025.
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sai Life Sciences has informed the stock exchanges that it will host an earnings conference call on Friday, 08 August 2025 at 4:00 PM IST to discuss its un-audited financial results for the quarter ended 30 June 2025 (Q1FY26). The call will begin with a brief management discussion on earnings performance, followed by a Q&A session. Senior management, including Managing Director & CEO Mr. Krishna Kanumuri and Director & CFO Mr. Siva Chittor, will represent the company. Dial-in numbers have been shared for domestic and international participants (USA, UK, Singapore, Hong Kong), along with a pre-registration link. The intimation is being made under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
This is a routine regulatory disclosure announcing the date and logistics of the upcoming Q1FY26 earnings call. It is neutral for the stock in the short term, but the actual results discussed on 08 August could move the share price. Investors should watch for the Q1FY26 numbers and management commentary on growth outlook.